- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05623605
Evaluation of New Different Herbal Mouthwashes Against Caries Forming Bacteria, RCT
December 12, 2022 updated by: GHada Abdelwahab Ahmed, Nahda University
Evaluation of Antibacterial Potency of New Different Herbal Mouthwashes Against Caries Forming Bacteria, a Randomized Control Trial
The goal of this randomized controlled trial is to compare three different types of mouthwash, Moringa, Star anis, and Indian Costus 90 children participated in this study divided into 3 groups according to the type of mouthwash used and then subdivided in each group into 3 subgroups according to the concentration of the mouthwash 5,10,15%.
the children were asked to rinse with the mouthwash 3 times per day for 1 week.
bacterial count for streptococcus mutans was measured before and after the use of mouthwash to see the most effective concentration.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The powdered of Moringa, Star anis, and Indian Costus leaves (250 g) were extracted using 90% ethanol then filtered using Whatman Filter paper No.1 and dried under reduced pressure using rota vapor.
The crude ethanolic extract was (200 mg).
ninety children will be randomly distributed into three groups (1,2,3) (30 children each).
each group was divided into further 3 groups (10 children each) according to the concentration of each herbal mouthwash (5,10,15%).
each participant will be given a new bottle of a specific effective amount of herbal extract to be used as a mouthwash.
Children will be instructed to rinse with 5ml of mouthwash.
All groups were instructed to rinse three times a day with specific mouthwash for each group for about one minute and participants will be advised to use the mouthwash for seven days.
Collection of saliva samples Prior to the start of the experiment, samples of unstimulated saliva were taken when the child spit a suitable amount of unstimulated saliva in a sterile container in the morning before breakfast.
Initial salivary samples were collected to establish base levels (S1) using selective culture media, The salivary samples (S2) were collected after one week of using the mouthwash when the child spit a suitable amount of unstimulated saliva in a sterile container in the morning before breakfast.
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ghada Salem, Ass. Professor
- Phone Number: +201005144561
- Email: ghada.abdelwahab@nub.edu.eg
Study Contact Backup
- Name: Mohamed Rashed, Ph.D
- Email: mf.helal@nrc.sci.eg
Study Locations
-
-
Cairo
-
Maadi, Cairo, Egypt, 11728
- Recruiting
- Ghada Salem
-
Contact:
- Ghada Salem, Ph.D
- Phone Number: +201005144561
- Email: ghadamohamedalirana@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- - Children with no systemic disease, no history of recent antibiotic administration (last 2 weeks), antimicrobial mouth-rinse (last 12 hours), topical fluoride treatment within 4 weeks prior to baseline, children with no untreated active carious lesion, no orthodontic appliance or with low caries index (DMF& def < 4)
Exclusion Criteria:
- Children using antibiotics, medications or mouthwashes at the time of the study, children with oral or systemic disease, children undergoing any dental treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Moringa mouthwash
5 ml Moringa mouthwash two times per day for 1 week
|
using Moringa mouthwashes in 3 different concentrations (5,10,15%) twice per day for 7 days
Other Names:
|
|
Experimental: Star Anis mouthwash
5 ml Star Anis mouthwash two times per day for 1 week
|
using star anise mouthwash in 3 different concentrations (5,10,15%) twice per day for 7 days
Other Names:
|
|
Experimental: Indian Costus mouthwash
5 ml Indian Costus mouthwash two times per day for 1 week
|
using Indian costus mouthwash in 3 different concentrations (5,10,15%) twice per day for 7 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
bacterial count
Time Frame: 1 weak
|
decrease the count of streptococus mutans after use of the herbal mouthwash
|
1 weak
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Mariem Elmansy, Ph.D, Researcher
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 19, 2022
Primary Completion (Anticipated)
December 13, 2022
Study Completion (Anticipated)
December 30, 2022
Study Registration Dates
First Submitted
November 12, 2022
First Submitted That Met QC Criteria
November 18, 2022
First Posted (Actual)
November 21, 2022
Study Record Updates
Last Update Posted (Actual)
December 14, 2022
Last Update Submitted That Met QC Criteria
December 12, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 040522
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries in Children
-
Cairo UniversityNot yet recruitingDental Caries in Children
-
Gül KeskinAlanya Alaaddin Keykubat UniversityRecruitingDental Caries in Children | Dental CariesTurkey (Türkiye)
-
Eslam samy abdel monaem kalboushNot yet recruitingDental Caries in ChildrenEgypt
-
Universidad Autonoma de Baja CaliforniaNot yet recruitingDental Caries in Children | Caries, Dental | Caries; DentinMexico
-
Children's Hospital Los AngelesUniversity of Southern CaliforniaCompletedDental Caries in Children | Dental Caries | Dental Caries Class IIUnited States
-
Universiti Putra MalaysiaRecruiting
-
University of Sao PauloNot yet recruitingDental Caries in Children | Dental CariesBrazil
-
Advantage Silver Dental Arrest, LLCCompletedDental Caries in ChildrenUnited States Minor Outlying Islands
-
University of GlasgowMinistry of Health, Saudi ArabiaCompleted
-
Suez Canal UniversitySuez canal university hospitalsCompletedDental Caries in ChildrenEgypt
Clinical Trials on Moringa mouthwash
-
Al-Azhar UniversityCompleted
-
Riphah International UniversityActive, not recruiting
-
Misr International UniversityNot yet recruitingPlaque, Dental | Cytotoxicity | Antimicrobial | Mouthwash
-
University of California, BerkeleyUniversity of California, DavisCompletedConsumption | Side Effect | AcceptabilityUnited States
-
Universidad de ColimaInstituto Mexicano del Seguro SocialCompletedMetabolic Syndrome | Nutritional and Metabolic DiseasesMexico
-
Government Dental College and Research Institute...Himalaya Drug Company Research and Development, Makali, Bangalore, IndiaCompletedDentinal Hypersensitivity
-
University of KentuckyUniversity of IdahoCompleted
-
King Abdullah University HospitalJordan University of Science and TechnologyRecruitingGingivitis | Dental Plaque | Gingival Inflammation | Gingival Bleeding | Patient Reported Outcome | Gingival Inflammation and BleedingJordan
-
Lacer S.A.CompletedDamaged Oral MucosaSpain
-
University of PlymouthRecruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom